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Cleavage factor Im (CF Im) is required for the first step
in pre-mRNA 3-end processing and can be reconstituted
in vitro from its heterologously expressed 25- and 68-
kDa subunits. The binding of CF Im to the pre-mRNA is
one of the earliest steps in the assembly of the cleavage
and polyadenylation machinery and facilitates the re-
cruitment of other processing factors. We identified re-
gions in the subunits of CF Im involved in RNA binding,
protein-protein interactions, and subcellular localiza-
tion. CF Im68 has a modular domain organization con-
sisting of an N-terminal RNA recognition motif and a
C-terminal alternating charge domain. However, the
RNA recognition motif of CF Im68 on its own is not
sufficient to bind RNA but is necessary for association
with the 25-kDa subunit. RNA binding appears to re-
quire a CF Im68/25 heterodimer. Whereas multiple pro-
tein interactions with other 3-end-processing factors
are detected with CF Im25, CF Im68 interacts with
SRp20, 9G8, and hTra2, members of the SR family of
splicing factors, via its C-terminal alternating charge
domain. This domain is also required for targeting CF
Im68 to the nucleus. However, CF Im68 does not concen-
trate in splicing speckles but in foci that partially colo-
calize with paraspeckles, a subnuclear component in
which other proteins involved in transcriptional control
and RNA processing have been found.
Eukaryotic mRNA precursors (pre-mRNAs)1 are synthesized
and processed in the nucleus prior to their export to the cyto-
plasm where they serve as templates for protein synthesis.
Transcription is coupled spatially and temporally to the cap-
ping of the pre-mRNA at the 5-end, splicing, and 3-end for-
mation. The mature 3-ends of most eukaryotic mRNAs are
generated by endonucleolytic cleavage of the primary tran-
script followed by the addition of a poly(A) tail to the upstream
cleavage product (for reviews see Refs. 1 and 2). In mammals,
these reactions are catalyzed by a large multicomponent com-
plex that is assembled in a cooperative manner on specific
cis-acting sequence elements in the pre-mRNA. The cleavage
and polyadenylation specificity factor (CPSF) (3) recognizes the
highly conserved hexanucleotide AAUAAA, whereas the cleav-
age stimulation factor (CstF) (4) binds a more degenerate GU-
or U-rich element downstream of the poly(A) site. It has been
suggested that in vivo CPSF and CstF may become associated
with each other prior to pre-mRNA binding, recognizing the
two elements in a concerted manner (5). In addition, the cleav-
age reaction requires mammalian cleavage factor I (CF Im),
cleavage factor IIm (CF IIm), and poly(A) polymerase (PAP).
After the first step of 3-end processing, CPSF remains bound
to the upstream cleavage fragment and tethers PAP to the
3-end of the pre-mRNA (6). In the presence of the nuclear
poly(A)-binding protein 1 (PABPN1), PAP elongates the poly(A)
tail in a processive manner (6). These factors are both neces-
sary and sufficient to reconstitute cleavage and polyadenyl-
ation in vitro. However, the other proteins involved in either
transcription, such as the C-terminal domain of RNA polymer-
ase II, or capping (nuclear cap-binding complex) and splicing
(U2AF65) have been shown to greatly enhance the efficiency of
the first step of the reaction (7–9).
Three major polypeptides of 25, 59, and 68 kDa and one
minor polypeptide of 72 kDa copurify with CF Im activity from
HeLa cell nuclear extract (10). Reconstitution of CF Im activity
with recombinant proteins suggests that CF Im is a het-
erodimer consisting of the 25-kDa subunit and one of the larger
polypeptides (11). All of the three larger proteins appear to be
highly related in their amino acid sequence. Moreover, all of
the CF Im subunits are only present in metazoan organisms.
The primary sequence of the 25-kDa polypeptide contains a
NUDIX motif (12). The amino acid composition of the 68-kDa
protein has a domain organization that is reminiscent of spli-
ceosomal SR proteins. Members of the SR family of splicing
factors contain one or more N-terminal RNA recognition motifs
(RRMs) that function in sequence-specific RNA binding and a
C-terminal domain rich in alternating arginine and serine res-
idues, referred to as RS domain, which is required for protein-
protein interactions with other RS domains (13). In the 68-kDa
protein, the RRM and the RS-like domain are separated by a
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region with high proline content (47%). SR proteins bound to
specific RNA sequence elements are thought to recruit key
splicing factors, thus enhancing the recognition of splice sites
and controlling splice site selection in a concentration-depend-
ent manner (for review see Ref. 14). Previous experiments have
shown that preincubation of the RNA substrate with CF Im
reduces the lag-phase of the cleavage reaction (11). This obser-
vation suggests that the binding of this factor to the pre-mRNA
may be an early step in the assembly of the 3-end-processing
complex, such that CF Im could have a role similar to that of SR
proteins in spliceosome assembly. Recent SELEX experiments
identified a related set of sequences within the 3-untranslated
region of the pre-mRNA of its 68-kDa subunit to which CF Im
preferentially binds (15).
In this report, we describe the analysis of the functional
domains of the 25- and 68-kDa subunits of CF Im. To this end,
we generated several deletion and point mutants of the two
subunits. We expressed wild type and mutant proteins in het-
erologous systems and analyzed the purified proteins for pro-
tein-protein interactions and for RNA binding. We found that
the 25-kDa subunit of CF Im interacts not only with PAP (16)
but also with PABPN1. Although the amino acid composition of
this subunit does not display a known RNA recognition motif,
CF Im25 binds to RNA. Surprisingly, despite having an RRM,
CF Im68 does not bind very strongly to RNA but requires its
RRM for interaction with the 25-kDa protein instead. A yeast
two-hybrid screen with the RS-like domain of CF Im68 identi-
fied members of the SR family of splicing factors, suggesting
that CF Im may contribute to the coordination of splicing and
3-end formation. Furthermore, we investigated the subcellular
localization of CF Im. We found that CF Im subunits are local-
ized to the nucleus and accumulate within a few bright foci that
partially overlap with paraspeckles (17). Finally, we report
that the RS-like domain is sufficient for targeting the protein to
the nucleus.
EXPERIMENTAL PROCEDURES
Oligonucleotides—Oligonucleotides were synthesized either by Mi-





GGAG-3; GST-25-(161–227 sense), 5-GGGATTACATATGATTCCTG-







RRM, 5-GATCCCCCGGGAATGGCGGACGGCGTGGA-3; 3-RRM, 5-
CTTCGGGATCCCAGGAAATCTGTCCCCACC-3; 3-Pro, 5-CTTCGG-
GATCCCACTCAATGGCGTTCTTGC-3; BclI (5-end), 5-TGGGCATG-
ATCAGATAGA-3; Bsu36I (3-end), 5-GACCTAAGGGTGGACG-3;
RNP2 sense, 5-ATTGCATTATATATTGTAGTTCTAACATGGTGGAC-
3; RNP2 antisense, 5-GTCCACCATGTTAGAACTACAATATATAAT-






3; and 3-9G8B, 5-ACGGATCCTCAGTCCATTCTTTCAGGA-C-3.
Yeast Two-hybrid Screen—Yeast two-hybrid library screening and
analysis were performed as described in the HybriZAP-2.1 two-hybrid
protocol provided by Stratagene with the yeast strain YRG-2. The
C-terminal charged domain of CF Im68 (aa 481–551) was amplified by
PCR with the oligonucleotides ythSRs and ythSRas and then cloned
into the EcoRI and SmaI restriction sites of the yeast vector pBD-Gal4.
This construct was used to screen a pre-made HeLa cell cDNA library
that was cloned into the yeast vector pAD-GAL4 (Stratagene). Reporter
genes in the HybriZAP-2.1 vector system are -galactosidase (lacZ) and
histidine (HIS3). The ability to express the reporter HIS3 gene was
tested on SC plates lacking leucine, tryptophan, and histidine but
containing 25 mM 3-aminotriazole. -Galactosidase activity was de-
tected by filter lift assays (18). Library plasmids from positive colonies
were recovered in Escherichia coli and sequenced.
Recombinant Protein Expression and Purification—For expression of
recombinant GST fusion proteins in E. coli, the sequence of interest was
cloned into the polylinker region of the pGDV expression plasmid (19).
The coding region of CF Im25 was inserted into the NcoI and XhoI sites.
To express fragments of the 25-kDa subunit of CF Im, the open reading
frame was divided into three regions corresponding to amino acids
1–80, 81–160, and 161–227 that were amplified by PCR with the
respective primers. The GST-25 mutant containing an internal deletion
corresponding to amino acids 140–168 was obtained by digestion of the
cDNA with Tth111I and Bsu36I, filling-in of the extremities, and reli-
gation. To obtain recombinant GST-U2AF subunits, the entire U2AF65
and U2AF35 open reading frames were amplified by PCR from a HeLa
cDNA library with the oligonucleotides 5-U2AF65 and 3-U2AF65 and
5-U2AF35 and 3-U2AF35, respectively. The fragments were cloned
into the BamHI and XhoI sites of pGEX vector (Amersham Biosciences).
The CF Im68 mutants RS, RRM, RRM/Pro, and Pro/RS were gener-
ated by PCR with the respective oligonucleotides, cloned into
pGemTeasy (Promega), and sequenced by Centro Richerche Interdipar-
timentale Biotecnologie Innovative (Universita` di Padova). The frag-
ments were excised with XmaI and BamHI and cloned into pGDV that
had been linearized with the same enzymes.
E. coli BL21 (DE3) were transformed with these plasmids, and pro-
tein expression was induced with isopropyl-1-thio--D-galactopyrano-
side. Whereas GST-U2AF65, GST-25, and its deletion mutants were
present in high amounts in the soluble fraction, soluble full-length
GST-59 and GST-68 could neither be recovered from E. coli BL21 (DE3)
pLysS nor from Epicurian Coli BL21 codon plus (Stratagene). In con-
trast, the expression of several mutant derivatives was successful.
Although most of the induced proteins were in inclusion bodies, a
significant amount was present in the soluble fraction. The proteins in
the supernatant were bound to GST-Sepharose 4B (Amersham Bio-
sciences) and purified according to the manufacturer’s instructions.
Expression of wild type CF Im68 in baculovirus was achieved with
the BAC-To-BAC baculovirus expression system (Invitrogen). The en-
tire coding region together with 162 nucleotides of the 3-untranslated
region and eight additional adenosines was inserted into the EcoRI site
of the baculovirus transfer vector pFASTBAC-Hta. Recombinant vi-
ruses were prepared by transforming the plasmid into DH10BAC-com-
petent cells and inducing the formation of the recombinant bacmids.
High molecular weight DNA was then prepared from selected E. coli
clones, and 1–2 g were used to transfect 1 106 Spodoptera frugiperda
(Sf9) insect cells. After 2–3 days, the supernatant was recovered and1
ml of the virus was used to infect 2  106 cells that had been seeded on
a 10-ml plate. The plates were again incubated at 27 °C for 3–4 days. At
this stage, the cells were analyzed for protein expression by Western
blot analysis. 2 ml of the resulting virus was added to a 30-ml suspen-
sion culture of Sf9 cells at a concentration of 1  106 cells/ml. After 4–5
days, cells were harvested, washed in PBS, and resuspended in approx-
imately two packed volumes of lysis buffer (200 mM NaCl, 50 mM Tris,
10% glycerol, 0.02% Nonidet P-40, 0.5 mM phenylmethylsulfonyl fluo-
ride, 0.7 g/ml pepstatin, 0.4 g/ml leupeptin). The lysate was centri-
fuged after incubation on ice for 30 min, and proteins were purified by
Ni2-nitrilotriacetic acid affinity chromatography.
GST Pull-down Experiments—0.5–1 g of purified GST-25 protein
was incubated with 100 g of either HeLa cell nuclear extract or
whole cell extracts prepared from transfected HeLa or human embry-
onic kidney 293 cells for 1 h at 4 °C. 50 l of glutathione-Sepharose
beads then were added and incubated for an additional 2 h. The resin
was washed three times with 1 ml of IPP150. Proteins were eluted
with 2 Laemmli buffer and separated by 12% SDS-PAGE. Proteins
then were blotted onto nitrocellulose, and the membrane was probed
with anti-CF Im68 polyclonal antibodies or anti-T7 monoclonal anti-
body (Novagen).
[35S]Methionine (Amersham Biosciences) was used to label proteins
in a transcription/translation system (Promega). Purified GST or GST
fusion proteins (500 ng) were incubated with in vitro translated pro-
teins in 30 l of total reaction volume. Volumes were adjusted with GST
buffer (75 mM KCl, 50 mM Tris-HCl, pH 7.9, 10% glycerol, 10 nM reduced
glutathione, 0.01% Nonidet P-40, 1 mM dithiothreitol, 50 g/ml bovine
serum albumin). After incubation for 1 h at 4 °C, 25 l of glutathione-
Sepharose beads were added and the volume was adjusted to 500 l
with 1 PBS, 0.01% Nonidet P-40. Incubation was continued for 1 h,
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and the resin was washed three times with IPP150. Proteins were
eluted from the beads by the addition of 2 Laemmli buffer, separated
by 10% SDS-PAGE, and visualized by autoradiography.
CF Im subunits were cloned into the BlueScript vector (KS, Strat-
agene), which allows in vitro transcription/translation with the TNT-
coupled reticulocyte lysate system (Promega). The open reading frame
of the 25-kDa subunit was cloned into BamHI and EcoRI, respectively
(pBS25). The open reading frames of CF Im59 and CF Im68 were in-
serted into the EcoRI site of BlueScript (Stratagene). The CF Im68
mutant that carries two point mutations in the RNP2 motif
(G86V,N87V) was generated with two consecutive PCR reactions with
primers BclI (5-end), Bsu36I (3-end), RNP2 sense, and RNP2 anti-
sense. Two internal BclI and Bsu36I restriction sites were used to
substitute the wild type sequence with the PCR fragment carrying the
mutations.
The SR mutant was generated by PCR with pBS68 and primers
that contained the SphI (RS sense) and HindIII (RS antisense)
restriction sites. The amplified fragment was inserted into pBS68 that
had been digested with SphI and HindIII and resulted in a C-terminally
truncated version lacking aa 482–551 of the full-length protein.
RNA Binding Assays—GST pull-down experiments were adapted
from Dichtl and Keller (19). Approximately, 500 ng of GST fusion
protein were incubated with 30–100 fmol of labeled RNA under cleav-
age conditions (20) for 30 min at 30 °C. GST-Sepharose was added and
incubated for 1 h at 4 °C. The beads were washed extensively with 1
PBS, 0.01% Nonidet P-40 and resuspended in the proteinase K mixture.
After 30 min, the supernatant was transferred to a fresh tube and the
RNA was precipitated with ethanol and resolved on 6% denaturing
polyacrylamide gels.
For UV cross-linking experiments, 20-l reactions were set up on ice
as follows. To 8 l of premixture (2 mM dithiothreitol, 0.01% Nonidet
P-40, 20 mM creatine phosphate, 2% polyethylene glycol, 0.4 mM
cordycepin, 5 units/l RNA Guard, 0.025 g/l creatine kinase, 1.5 mM
MgCl2), either 1 pmol of CF Im25/68 and CF Im68, 5 pmol of CF Im25, or
4 pmol of purified CF Im was incubated with 200 fmol of labeled L3
pre-mRNA. These proteins had been expressed in E. coli and assembled
in vitro as described previously (11). 75 mM potassium acetate and 200
fmol of RNA substrate (resuspended in water) were added, and volumes
were adjusted with buffer E. Reactions were incubated for 10 min at
room temperature and exposed to UV light (2  250 mJ, UV Stratal-
inker 1800, Stratagene) in a microtiter plate at room temperature.
Samples were treated with 5 ng/l RNase A (Sigma) for 1 h at 37 °C,
and proteins were separated by SDS-PAGE and exposed on x-ray film.
Cell Culture and Transfections—HeLa and human embryonic kidney
293 cells were grown in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum and transfected with 1 g of plasmid
DNA/60-mm dish containing 60% confluent cells with the calcium
phosphate method. The epitope-tagged 9G8 and hTra2 expression
plasmids were constructed by amplifying the cDNAs isolated in the
yeast two-hybrid screen with specific primers and subcloning the re-
sulting PCR products as a XbaI-BamHI fragment into pCGTHCFFLT7
expression vector (21). Amplification was performed with Amplitaq
Gold (Roche Applied Science) and oligonucleotides (5-9G8X, 3-9G8B,
5-TraX, and 3-TraB) purchased from MWG. Construction of pCG-
SRp20 was described previously (22).
Indirect Immunofluorescence—Cells were either plated on glass cov-
erslips and transfected or distributed after transfection on polylysine-
coated coverslips. 24 h after transfection, cells were washed with PBS,
fixed with 3% paraformaldehyde, and permeabilized with 0.2% Triton
X-100 for 5 min on ice. Cells were incubated 1 h at 37 °C with the
primary antibody, washed three times with PBS containing 2% bovine
serum albumin, and again incubated for 1 h at 37 °C with the appro-
priate secondary antibody.
For localization of endogenous CF Im, polyclonal antibodies raised
against CF Im68 and CF Im25 (11) were used at a 1:500 and 1:200
dilution, respectively. Colocalization studies of GFP fusion proteins and
endogenous SRp20 protein were performed with a mouse monoclonal
antibody (Zymed Laboratories Inc.) used as a 1:100 dilution and de-
tected with a Texas Red-conjugated anti-mouse IgG (Molecular Probes,
1:1000) secondary antibody. SC35 was detected with a mouse mono-
clonal antibody (Sigma, 1:2000), and endogenous CPSF was detected
with a mouse monoclonal antibody (3). Secondary antibodies were Alexa
488-conjugated anti-mouse IgG or Alexa 594-conjugated anti-rabbit IgG
(Molecular Probes) used as a 1:1000 dilution.
GFP expression plasmids were constructed by cloning DNA frag-
ments encoding full-length and mutant CF Im68 into pEGFP-C1 plas-
mid (Clontech). GFP-68 was obtained by digesting pBS68 with BamHI
and SalI and inserting the two fragments that are generated (BamHI/
SalI and SalI/SalI) into pEGFP-C1 linearized with BglII and SalI.
GFP-68 deletion mutants were excised from the corresponding GST
constructs with XmaI and BamHI (filled) and cloned into pEGFP-C1
linearized with XmaI and XbaI (filled).
Confocal Fluorescence Microscopy—Fluorescence microscopy of fixed
cells was carried out with a Nikon YFL microscope equipped with a
60, 1.4 oil Plan-Apochromat objective or a Leica DM IRE2 confocal
microscope equipped with an argon/krypton laser (488 nm) to excite
GFP fluorescence and a helium/neon laser (543 nm) to excite the Alexa
594 fluorescence and a 63, 1.4 oil HCX Plan-Apochromat objective.
For double-labeling experiments, images from the same focal plane
were sequentially recorded in different channels and superimposed.
RESULTS
CF Im68 Interacts with the 25-kDa Protein via Its RRM—
Four polypeptides with apparent molecular masses of 25, 59,
68, and 72 kDa copurified with CF Im activity. Previous studies
have shown that the 25- and 68-kDa proteins are sufficient to
reconstitute CF Im activity in vitro. It has been suggested that
CF Im forms a heterodimer composed of the 25-kDa subunit
and one of the larger polypeptides, which seem to be related as
they are recognized by the same antibody that was raised
against the 68-kDa protein (11). To verify that the larger CF Im
subunits associate with the 25-kDa protein, we expressed the
25-kDa protein as a GST fusion (GST-25) in E. coli and incu-
bated it with HeLa cell nuclear extract. Western blot analysis
with anti-CF Im68 antibody detected all three larger CF Im
subunits (Fig. 1A, lane 3). This result was confirmed by incu-
bating GST-25 with CF Im68 and CF Im59 that had been
transcribed and translated in vitro in the presence of [35S]me-
thionine (Fig. 1B, lanes 7 and 8). In addition, CF Im25 appeared
to interact weakly with itself (Fig. 1B, lane 9), which might
indicate that heterodimers bind to each other to form larger CF
Im complexes. The experiments were carried out in the pres-
ence of RNase A, and the interactions thus were not mediated
through RNA.
Since no known protein-protein interaction motif has so far
been identified in the sequence of the 25-kDa polypeptide, we
wished to map the region responsible for its binding to CF Im68.
For this purpose, the fragments of the 25-kDa protein were
expressed as GST fusions in E. coli (a schematic representation
of the different mutants is shown in Fig. 1C). Pull-down exper-
iments performed with the GST-25 fragments and in vitro
transcribed/translated CF Im68 only detected association with
the full-length GST-25 (Fig. 1C, lane 3). None of the deletion
constructs was able to interact with CF Im68, suggesting that
intact 25-kDa protein is required for the stable binding of the
two proteins.
CF Im25 Interacts with PAP and PABPN1—The binding of
CPSF and CstF to conserved sequence elements in the
pre-mRNA located upstream and downstream of the poly(A)
site mediates specific recognition of the polyadenylation site.
As has been shown previously, the association of CF Im with the
substrate leads to a faster assembly of the 3-end-processing
complex (11). Therefore, CF Im may help to recruit CPSF and
CstF to the pre-mRNA. To test this hypothesis, we tested in
GST pull-down experiments for the direct interaction of CF Im
with CPSF and CstF. However, our results with GST-25 sug-
gest only weak association with in vitro transcribed/translated
CstF50, CstF77, and CPSF160 and no detectable interaction
with the other CstF and CPSF subunits (results not shown).
Therefore, if the recruitment of CstF and CPSF is facilitated by
CF Im, this does not appear to be mediated by a direct interac-
tion with the smallest subunit of CF Im.
An interaction between CF Im25 and PAP has been described
previously (16). The authors isolated the 25-kDa subunit of CF
Im in a yeast two-hybrid screen with the C-terminal domain of
mouse PAP (aa 472–739) as a bait. In addition to PAP, we
found that GST-25 interacts with PABPN1 (Fig. 2A, lane 8). A
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deletion of the C-terminal 226 residues of PAP did not affect its
binding to GST-25 (Fig. 2A, PAPC, lane 5). Incubation of
GST-25 with HeLa cell nuclear extract and subsequent West-
ern blot analysis confirmed the interaction of GST-25 with PAP
and PABPN1 (results not shown).
The region within CF Im25 responsible for its interaction
with PAP and PABPN1 was mapped and is shown in Fig. 2B.
GST fragments comprising amino acids 1–80, 81–160, 161–
227, 1–160, and 81–227 of CF Im25 were incubated with in vitro
transcribed/translated PABPN1. The full-length 25-kDa pro-
tein was able to efficiently interact with PABPN1 (Fig. 2B, lane
3), and a weaker interaction was found with fragment 81–160
(Fig. 2B, lane 7). Several experiments confirmed that weak
interactions could take place with the constructs comprising
amino acids 1–160 and 81–227 (Fig. 2B, lanes 4 and 5, respec-
tively), emphasizing that mainly the region between amino
acids 81 and 160 of CF Im25 mediates association with
PABPN1. Similar results were obtained with PAP (results not
shown), suggesting that PAP and PABPN1 may share the same
binding site on CF Im25 or that their interaction domains are
very close.
The N-terminal RRM of CF Im68 Is Sufficient for the Inter-
action with CF Im25—To identify functional domains of the
68-kDa subunit of CF Im, we took a similar approach to that
used for the characterization of CF Im25. Several CF Im68
deletion and point mutants were generated and cloned into a
bacterial expression vector (Fig. 3A). Unfortunately, neither
the full-length 68-kDa protein nor any of the mutants contain-
ing the proline-rich domain within the central region, with the
exception of the Pro/RS fragment, could be efficiently expressed
as GST fusion proteins in E. coli. In vitro translated CF Im25
was found to associate with both GST-68RRM and GST-
68RRM/RS (Fig. 3B, lanes 3 and 5) but not with the GST-68RS
or GST-68Pro/RS fragments (Fig. 3B, lanes 4 and 6). These
results were confirmed by pull-down assays in which recombi-
nant GST-25 was incubated with in vitro translated wild type
or mutant CF Im68. As shown in Fig. 3C, both wild type CF
Im68 and a C-terminal truncation lacking the RS-like domain
are efficiently precipitated by GST-25 (Fig. 3C, lanes 3 and 6
respectively). Instead, the substitution of two amino acids
within the RNP2 motif of the RRM of CF Im68 (G87V,N88V)
abolished interaction with the 25-kDa subunit (Fig. 3C, lane 9).
These results suggest that the interaction between CF Im68
and CF Im25 is mediated by the RRM and, in particular, by the
RNP2 motif within the 68-kDa protein.
The 25-kDa Subunit Is the Major RNA-binding Component of
CF Im—Whereas the 68-kDa subunit of CF Im contains an
RRM, the 25-kDa polypeptide does not display homology to any
FIG. 1. The 25-kDa protein interacts with the larger CF Im subunits. A, the 25-kDa protein can coprecipitate the large subunits from
nuclear extract. GST protein (lane 2) or GST-25 (lane 3) was preincubated with HeLa cell nuclear extract as described under “Experimental
Procedures.” GST-Sepharose-bound proteins were resolved by SDS-PAGE and analyzed by Western blotting with a polyclonal antibody specific for
the larger CF Im subunits (11). Lane 1, 2 g of HeLa cell nuclear extract. B, GST-25 interacts directly with CF Im59, CF Im68, and with itself. In
vitro translated [35S]methionine-labeled 25-, 59-, and 68-kDa polypeptides were incubated with either GST or GST-25 protein as described under
“Experimental Procedures.” Bound proteins were analyzed by SDS-PAGE and autoradiography. 10% of the input was loaded in lanes 1, 2, and 3.
C, interaction with CF Im68 requires a full-length 25-kDa protein. In vitro translated [
35S]methionine-labeled CF Im68 subunit was incubated with
the indicated purified GST fusion proteins (GST-25, GST-25/1–80, GST-25/81–160, GST-25/161–227, GST-25/1–160, GST-25/81–227, or GST-25/
140–168) as described under “Experimental Procedures.” Bound proteins were analyzed by SDS-PAGE and autoradiography. 10% of the input
is shown in lane 1. A schematic representation of the recombinant 25-kDa proteins used in this study is shown in the upper panel. The position
of the NUDIX domain is indicted by the shaded box. NE, nuclear extract.
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known RNA binding domain. Nevertheless, it was shown pre-
viously that the CF Im subunits purified from HeLa cell nuclear
extract can be UV-cross-linked to an RNA substrate (10). We
analyzed the interaction of CF Im subunits with RNA in more
detail. In a first attempt, we performed UV-cross-linking ex-
periments with recombinant CF Im68 purified from baculovi-
rus-infected Sf9 cells and recombinant CF Im25 produced in E.
coli. Similar amounts of proteins were exposed to UV light in
the presence of 32P-labeled pre-mRNA substrate (for details see
“Experimental Procedures”). The first lane of Fig. 4A shows
that in addition to the 59-kDa protein, the 25- and 68-kDa
subunits of CF Im, which had been purified from HeLa cells,
could be UV-cross-linked to RNA. However, when the single
recombinant subunits were assayed separately for RNA bind-
ing, only the 25-kDa protein could efficiently be cross-linked to
RNA (Fig. 4A, lane 2), whereas the signal detected with the
68-kDa polypeptide was very weak (Fig. 4A, lane 3). In con-
trast, the cross-linking efficiency of CF Im assembled in vitro
from recombinant 25- and 68-kDa polypeptides was compara-
ble to that obtained with the purified factor (Fig. 4A, lane 4).
These results suggest that a heterodimer consisting of the 25-
and the 68-kDa proteins binds RNA more efficiently than each
subunit separately.
To determine which region of the 25-kDa subunit of CF Im
was responsible for the interaction with the pre-mRNA, the
same GST fragments that were previously used for the protein-
protein interaction experiments (Fig. 1C) were assayed in an
RNA pull-down experiment. The different GST fragments were
incubated under cleavage conditions with the labeled sub-
strate, and RNA-protein complexes were subsequently immo-
bilized on GST-Sepharose. Fig. 4B shows that the fragment
consisting of amino acids 1–160 binds to RNA as efficiently as
the full-length GST-25 (Fig. 4B, lanes 2 and 3). Smaller frag-
ments comprising amino acids 1–80 and 81–160, respectively,
also interact with RNA albeit weaker (Fig. 4B, lanes 5 and 6),
whereas the C-terminal fragment (aa 161–227) and the frag-
ment consisting of amino acids 81–227 fail to do so. We con-
clude from our data that the C-terminally 80 amino acids are
not required for RNA binding.
In a similar way, we also mapped the RNA binding region of
the 68-kDa polypeptide. As shown in Fig. 4C, the N-terminal
fragment containing the RRM did not significantly bind the
RNA (lanes 3–6). In contrast, both the C-terminal RS-like
domain and the RRM/RS fusion polypeptides were able to effi-
ciently pull-down the substrate (lanes 7–14). This probably
reflects an ionic interaction between the positively charged
RS-like domain and the RNA.
Synergistic RNA binding of CF Im25 and CF Im68 was con-
firmed by RNA pull-down assays with the same GST-68 pro-
teins used before and in the presence of increasing amounts of
the recombinant histidine-tagged 25-kDa subunit (Fig. 4D,
His-CF Im25). The addition of the 25-kDa subunit increased the
amount of RNA precipitated by the GST-RRM/RS protein (Fig.
4D, lanes 13–16) and enabled the GST-RRM fragment to pull-
down RNA (Fig. 4D, lanes 3–6). This could be explained by the
concomitant interaction of the 25-kDa polypeptide with the
RNA and the GST-tagged RRM fragment of the 68-kDa protein.
The addition of CF Im25 to the RS-like domain of CF Im68 did
not increase the amount of precipitated RNA (Fig. 4D, lanes
8–11), most probably because the 25-kDa protein cannot inter-
act with GST-68RS. Taken together, these results suggest that
the 25-kDa protein and one of the larger subunits cooperate to
recognize the CF Im binding sites on the pre-mRNA.
The RS-like Domain of CF Im68 Associates with SR Pro-
teins—The C-terminal portion of CF Im68 consists of RD-, RE-,
and RS-dipeptide repeats up to a total length of 60 amino acids.
Similar alternating charge domains consisting of RS repeats
have been described to occur in a family of splicing factors
termed SR proteins. The RS domain has been shown to promote
protein-protein interactions, direct subcellular localization,
and, in certain situations, nucleocytoplasmic shuttling. To iso-
late proteins that interact with the C terminus of CF Im68, a
yeast two-hybrid screen was performed with a fragment encod-
ing amino acids 481–551 (called 68RS) as bait. A HeLa cell
cDNA library was screened, and an analysis of positive colonies
revealed among the strongest interactors some known mem-
bers of the SR protein family, namely hTra-2 (23, 24), SRp20
(also named X16) (25), and 9G8 (26).
To verify these interactions in vivo, we used GST-68RS in
pull-down assays with total extracts of human cells transfected
with plasmids encoding cDNAs for hTra-2, SRp20, and 9G8
(Fig. 5A). All of the constructs encoded proteins with a bacte-
riophage T7 gene 10 (T7) epitope tag at their N termini, allow-
ing the detection of the exogenous proteins with a monoclonal
antibody that recognizes this epitope (see “Experimental Pro-
cedures”) (21). Western blot analysis revealed that a significant
fraction of hTra-2, SRp20, and 9G8 was found to associate
with the RS-like domain of CF Im68 (Fig. 5, lane 3 of each
panel). However, none of those SR proteins was detected if
FIG. 2. The central region of CF Im25 is required for the inter-
action with PAP and PABPN1. A, GST-25 directly interacts with
PAP and PABPN1. GST (lanes 3, 6, and 9) or GST-25 (lanes 2, 5, and 8)
was preincubated with in vitro translated [35S]methionine-labeled PAP,
PAPC, or PABPN1 proteins as described under “Experimental Proce-
dures.” Bound proteins were analyzed by SDS-PAGE and autoradiog-
raphy. 10% of the input is shown in lanes 1, 4, and 7. B, residues 81–160
of CF Im25 are sufficient for interaction with PABPN1. In vitro trans-
lated [35S]methionine-labeled PABPN1 was incubated with the indi-
cated purified GST fusion proteins (GST-25, 1–160, 81–227, 1–80, 81–
160, or 161–227) as described under “Experimental Procedures.” Bound
proteins were analyzed by SDS-PAGE and autoradiography. 10% of the
input is shown in lane 1.
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incubated with GST (lane 1), GST-25 (lane 2), GST-RRM68
(lane 4), or GST-U2AF65 (lane 5), indicating that the interac-
tion is specific for the RS-like domain of CF Im68. The interac-
tion with hTra-2, SRp20, and 9G8 was confirmed in vitro by
GST-pull down experiments with in vitro transcribed/trans-
lated proteins (results not shown). These results indicate that
CF Im68 interacts directly with a specific subset of SR proteins,
raising the intriguing possibility that CF Im contributes to the
definition of the last exon during the processing of intron-
containing pre-mRNAs.
CF Im Localizes in a Punctate Pattern in the Nucleus—Sev-
eral studies have addressed the subcellular distribution of com-
ponents of the 3-end-processing machinery. CstF64 and
CPSF100 were found concentrated in foci adjacent to Cajal
bodies that were termed “cleavage bodies” to reflect their con-
tent of pre-mRNA cleavage factors (28). Different 3-end for-
mation factors can also accumulate at sites of transcription
(29). Despite being a polyadenylation factor, PABPN1 appears
to localize in nuclear speckles (30). Speckles (also known as
“interchromatin granule clusters”) are subnuclear structures
that are believed to serve as storage sites for splicing factors,
including SR proteins (for review see Ref. 31). The RS domain
is a major determinant for the subcellular localization of SR
proteins to speckles, and it can also function as a nuclear
localization signal (22, 33).
Because of the similarity of CF Im large subunits and SR
proteins, we wanted to determine their subcellular localization.
Immunofluorescence microscopy with polyclonal antisera
raised against the 25- and the 68-kDa CF Im subunits (11)
revealed that endogenous CF Im is localized in the nucleoplasm
with the exclusion of the nucleoli, with a granular distribution,
and with concentration in few discrete foci (Fig. 6, c and c). To
confirm the staining pattern observed with the antibodies, we
transiently expressed both CF Im subunits fused to the GFP. A
portion of the transfected cell population expressed the GFP
fusion proteins at very high levels and showed aberrant local-
ization patterns. Therefore, we selected cells that expressed
low levels of the GFP fusion proteins. In these cells, indirect
immunofluorescence showed that, 20–24 h after transfection,
the transiently expressed GFP-68 and GFP-25 localized exclu-
sively to the nucleus with a diffuse pattern and, in addition,
within a few distinct foci, in agreement with the localization
observed with the specific antibodies (Fig. 6, b and b). To
determine whether these foci corresponded to cleavage bodies,
we performed double-labeling experiments with a monoclonal
antibody that specifically recognizes the 100-kDa subunit of
CPSF (3). However, Fig. 7A shows that the foci detected with
anti-CF Im68 do not correspond to cleavage bodies visualized by
anti-CPSF100. This unexpected result prompted us to assay
markers for known subnuclear compartments to clarify the
nature of the CF Im foci. We used antibodies specific for p80
coilin to detect Cajal bodies (34) and for SC-35 to detect splicing
speckles (35, 36). However, GFP-68 was neither localized to
Cajal bodies (Fig. 7B, panels a–a) nor to speckles (Fig. 7B,
panels b–b) but was always localized in close proximity to both
of them. The observation that GFP-68 foci were adjacent to
speckles prompted us to colocalize GFP-68 and the recently
identified PSP1 protein (17). This protein accumulates in punc-
tate subnuclear structures that are frequently localized adja-
cent to SC35 speckles and, therefore, are termed paraspeckles.
Fig. 7B (panels c–c) shows that GFP-68 and PSP1, at least
partially, colocalize in paraspeckles.
Role of Individual Domains of CF Im68 in Cellular Distribu-
tion and Subnuclear Localization—To determine the role of
individual domains of CF Im68 in nuclear and subnuclear lo-
calization, we transiently overexpressed cDNAs encoding sev-
eral mutant derivatives (listed in Fig. 3A) as GFP fusion pro-
teins in HeLa cells and determined the cellular distribution of
FIG. 3. The RRM domain of CF Im68
is required for the interaction with
the 25-kDa protein. A, schematic repre-
sentation of the CF Im68 domain mutants.
The open and solid boxes indicate the re-
gions of the proteins present in each mu-
tant relative to the 552 amino acid wild
type protein shown at the top. Asterisks
represent substituted amino acids within
the RNP2. The line indicates that resi-
dues 222–419 are missing in the RRM/RS
protein. The regions required for protein-
protein interaction and RNA-binding are
indicated. B, CF Im68 interacts directly
with the 25-kDa subunit via the RRM
domain. In vitro translated [35S]methi-
onine-labeled CF Im25 subunit was incu-
bated with the purified GST fusion pro-
teins indicated (68RRM, 68RS, 68RRM/
RS, or 68Pro/RS) as described under
“Experimental Procedures.” Bound pro-
teins were analyzed by SDS-PAGE and
autoradiography. 10% of the input is
shown in lane 1. C, residues within the
RRM and in particular the RNP2 motif of
CF Im68 are essential for the interaction
with CF Im25. GST (lanes 2, 5, and 8) or
GST-25 (lanes 3, 6, and 9) was preincu-
bated with the indicated in vitro trans-
lated [35S]methionine-labeled proteins
(CF Im68, 68RS, and 68RNP2) as de-
scribed under “Experimental Proce-
dures.” In the 68RNP2 mutant protein,
glycine 86 and asparagines 87 within the
RNP2 were changed to valines. Bound
proteins were analyzed by SDS-PAGE
and autoradiography. 10% of the input is
shown in lanes 1, 4, and 7.
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the proteins by indirect immunofluorescence microscopy (Fig.
8). We verified the expression of all of the transfected cDNAs by
Western blot analysis of whole cell lysates (results not shown).
Whereas GFP alone was diffusely distributed throughout the
cell (Fig. 8, panel a), mutant proteins in which the N-terminal
RNA binding domain was either deleted (Fig. 8, 68N, panel b)
or carried amino acid substitutions in the RNP2 of the RRM
(results not shown) were concentrated in the nucleus (exclud-
ing the nucleoli), similarly to the wild type protein (Fig. 6). All
of the deletion mutants lacking the C-terminal RS-like domain
localized to the cytoplasm (Fig. 8, 68RS46, panel c; RRM and
RRM/Pro, data not shown). Interestingly, a domain search with
PSORT (37) reveals the presence of a putative nuclear local-
ization signal (RRHR) located 46 amino acids upstream of the
stop codon. Consistent with this prediction, the deletion of this
portion of the charged domain was sufficient to prevent nuclear
import of the truncated protein (Fig. 8, 68RS46, panel c). The
requirement for the RS domain for nuclear localization was
confirmed by the cellular distribution of a mutant protein in
which the N-terminal RRM is fused directly to the RS-like
domain (Fig. 8, RRM/RS, panel d). This protein was found
both in the cytoplasm and in the nucleus. Furthermore, the
FIG. 4. The small and the large subunit of CF Im cooperate in RNA binding. A, CF Im subunits can be UV-cross-linked to RNA.
32P-Labeled adenovirus L3 pre-mRNA was incubated for 10 min with the indicated proteins (pCF Im, purified CF Im; rCF Im, recombinant CF Im)
and exposed to UV light as described under “Experimental Procedures.” After digestion with RNaseA, the products were analyzed by 12%
SDS-PAGE and autoradiography. B, the N-terminal region of CF Im25 is required for RNA binding. RNA pull-down experiment with GST fusions
of CF Im25 deletion mutants.
32P-Labeled SV40 pre-mRNA was incubated with the indicated purified GST fusion proteins as described under
“Experimental Procedures.” Lane 1, GST protein. C, the CF Im68RRM domain does not bind to RNA. RNA pull-down experiment with GST fusions
of CF Im68 domain deletion mutants is shown.
32P-Labeled adenovirus L3 substrate was incubated with the indicated purified GST fusion proteins
as described under “Experimental Procedures.” Lane 1, 10% of the input L3 pre-mRNA; lane 2, GST protein. D, CF Im25 interacts with the RRM
of CF Im68 and enhances binding to RNA. RNA pull-down experiment with GST fusions of CF Im68 domain deletion mutants either in the absence
(lanes 2, 7, and 12) or in the presence of increasing amounts of the recombinant histidine-tagged 25-kDa subunit (lanes 3–6, 8–11, and 13–16) is
shown. 32P-Labeled adenovirus L3 substrate was incubated with the indicated purified GST fusion proteins as described under “Experimental
Procedures.” Lane 1, 10% of input L3 pre-mRNA; lane 17, GST protein; lanes 18–19, increasing amounts of histidine-tagged 25-kDa protein.
FIG. 5. The C-terminal RS-like domain of CF Im68 interacts with SR proteins. HeLa or human embryonic kidney 293 cells were
transfected with pCG constructs expressing hTra2, SRp20, or 9G8. Whole cell extracts were incubated with either GST or the indicated GST
fusion proteins (GST-25, GST-68RS, GST-68RRM, and GST-U2AF65) as described under “Experimental Procedures.” Bound proteins were
separated by SDS-PAGE and analyzed by Western blotting with an anti-T7 tag monoclonal antibody.
Domain Organization of Human Cleavage Factor Im35794
fusion of the RS domain to GFP is sufficient to direct nuclear
import of the chimeric protein (Fig. 8, 68RS, panel e). These
results indicate that the C-terminal charged domain may con-
tain one or more nuclear localization signals.
DISCUSSION
CF Im is a component of the basic pre-mRNA 3-end-process-
ing complex. Reconstitution experiments suggest that CF Im
occurs as several isomers consisting of a heterodimer of a
25-kDa polypeptide and one of the three larger subunits of 59,
68, and 72 kDa (11). In this work, we have characterized the
functional domains of the 25- and 68-kDa subunits. The small
subunit lacks any known sequence motif involved in RNA bind-
ing or protein-protein interactions. However, our results sug-
gest that the central part of CF Im25 (aa 81–160) mediates
specific interactions with PAP and PABPN1. In contrast, the
intact protein is required for association with the 68-kDa pro-
tein, indicating that a heterodimeric interaction of the 25-kDa
protein with the 68-kDa polypeptide is essential for binding to
the pre-mRNA substrate. This view is supported by recent
SELEX experiments with a CF Im68/25 heterodimer that iden-
tified specific binding sites on the RNA (15). The RNA binding
of CF Im25 per se does not require the C terminus of the protein.
The primary sequence of CF Im68 reveals the presence of two
known sequence motifs: an N-terminal RRM of the RNP type
and a C-terminal alternating charge domain enriched in RS,
RD, and RE repeats that resembles the RS domain of spliceo-
somal SR proteins. Our results indicate that the RRM of CF
Im68 is primarily engaged in protein-protein interaction with
the 25-kDa subunit of CF Im. Although RRMs are generally
considered nucleic acid binding domains, several reports have
implicated them in protein-protein interactions. For example,
the U2 small nuclear RNP-specific protein U2B was found to
interact with U2A via its RRM (38). Recently, the crystal
structure of the complex between the Drosophila melanogaster
Y14 and Mago proteins was determined (39). Y14 and Mago
associate with spliced mRNAs and are components of the exon
junction complex. Similar to CF Im25, Mago does not reveal
recognizable motifs. Whereas the amino acid sequence of Y14
predicts a canonical RRM, the structure of the complex reveals
that Y14 RRM is engaged in protein recognition rather than in
RNA binding. A similar interaction occurs between the two
subunits of the splicing factor U2AF. Human U2AF is a het-
erodimer composed of a 65-kDa large subunit (U2AF65) and a
35-kDa small subunit (U2AF35). It was shown that the atypical
RRM of U2AF35 interacts with the proline-rich region of
U2AF65 (40). In addition, U2AF65 was found to bind to the
human splicing factor SF1 via its noncanonical third RRM (41).
As in the case of U2AF where both subunits work in concert to
recognize weak polypyrimidine tracts and promote U2 small
nuclear RNP binding, we suspect that the 25-kDa protein and
one of the larger subunits of CF Im cooperate to recognize the
CF Im binding sites on the pre-mRNA and thus promote as-
sembly of the 3-end-processing complex.
The isolation of three SR proteins in a yeast two-hybrid
screen with the RS-like domain of CF Im68 provides new in-
sight into the coordination of splicing and 3-end formation.
Recognition of the 3-terminal exons has been postulated to
involve an interaction of splicing and polyadenylation factors,
and a growing number of reports support this view (42–50).
Because the RS domain of SR proteins mediates protein-pro-
tein interactions that are important for spliceosome assembly
FIG. 6. Nuclear localization of CF Im subunits. HeLa cells were
either immunolabeled with anti-CF Im68 (panel c) or with anti-CF Im25
(panel c) polyclonal antibodies (11) or transfected with GFP fusion
constructs (panel b, GFP68; panel b, GFP25) as described under “Ex-
perimental Procedures.” Panels a and a, 4,6-diamidino-2-phenylindole
staining. The white arrowheads indicate punctuate CF Im foci. Scale
bars, 5 m.
FIG. 7. CF Im68 localizes to paraspeckles. A, double labeling of
HeLa cells with anti-CPSF100 monoclonal antibody (panel a) (3) and
with anti-CF Im68 polyclonal antiserum (panel b) (11) as described
under “Experimental Procedures.” Is shown. The merge of the two
channels is shown in panel c (green, anti-CPSF100; red, anti-CF Im68).
Small arrows indicate the cleavage bodies that can be detected with the
anti-CPSF100 antibody (3). Arrowheads indicate discrete CF Im68 foci
that do not colocalize with CPSF cleavage bodies. B, CF Im68 partially
colocalizes with PSP1 protein. HeLa cells were transiently transfected
with a plasmid expressing GFP-68 protein. The cells were fixed and
immunostained with antibodies against nuclear markers (red). Endog-
enous proteins were detected with specific antibodies followed by Alexa
594-conjugated secondary antibody as described under “Experimental
Procedures.” Three sequential focal planes are shown. Cajal bodies
were detected with a polyclonal anti-p80 coilin antiserum (a–a) (28).
Arrowheads indicate adjacent GFP-68 foci (green) and coiled bodies
(red). b–b, splicing speckles are detected with an anti-SC35 monoclonal
antibody (Sigma). Arrowheads indicate adjacent GFP-68 foci (green)
and speckles (red). c–c, paraspeckles are detected with an anti-PSP1
polyclonal antiserum (16). Arrowheads indicate colocalization of
GFP-68 and PSP1 (yellow).
Domain Organization of Human Cleavage Factor Im 35795
(51), it has been suggested that CF Im68 could interact via its
C-terminal alternating charge domain with one or more SR
proteins and/or SR-related splicing factors (for review see Ref.
51). Two recent reports identified CF Im as a component of
purified spliceosomes (52, 53). SRp20 and 9G8 that were iden-
tified in our screen belong to the family of SR proteins that
function in the constitutive splicing reaction and also as alter-
native splicing regulators (25, 54). Moreover, SRp20 has been
shown to mediate the recognition of an alternative 3-terminal
exon by affecting the efficiency of CstF binding to the
pre-mRNA (55).
hTra2 is one of the two homologues of the alternative
splicing regulator of the D. melanogaster sex determination
cascade. It binds to purine-rich exonic splicing enhancers (56)
and was reported to promote exon 7 inclusion of the “survival
of motor neuron 2” mRNA in vivo (57). Therefore, our results
suggest that CF Im68 through the interaction with a specific
subset of SR proteins could participate in the definition of the
last exon and in the choice between alternative 3-terminal
exons. It is interesting to note that both CF Im68 and CF Im25
but not the 59-kDa polypeptide have been found in purified
spliceosomes (52, 53). So far, we have been unable to demon-
strate an interaction of CF Im59 with SR proteins, albeit this
CF Im subunit also possesses an RS-like C-terminal domain.
2
The large subunit of CF Im has a modular domain organiza-
tion consisting of an N-terminal RRM, a proline-rich central
region, and a C-terminal RS-like domain. Our results suggest
that each of these domains contributes to the correct intracel-
lular distribution of the protein. In particular, the RS-like
domain is a major determinant for CF Im68 nuclear localiza-
tion since fusion of this domain to GFP results in exclusive
nuclear distribution. In contrast, the RRM does not appear to
contain any nuclear targeting signal. Fusion of this region to
GFP results in a diffuse distribution throughout the cell,
similar to that of GFP alone. However, when the RRM is
fused to the RS-like domain, the resulting polypeptide is
predominantly nuclear but cytoplasmic as well. We do not
know at present whether the nuclear and cytoplasmic distri-
butions observed with this mutant protein represent incom-
plete nuclear import and/or incomplete retention of the pro-
tein in the nucleus. The cytoplasmic and nuclear
distributions of the RRM/RS mutant could be explained by
the absence of the proline-rich region that may contain a
weak nuclear localization signal that is required for complete
nuclear targeting. This explanation is consistent with the
observation that a mutant lacking the entire RS-like domain
is still partially nuclear (results not shown). Alternatively,
the central proline-rich part of CF Im68 could contain a
nuclear retention signal (NRS). The first NRS has been iden-
tified in human RNP C1, a non-shuttling human RNP that
contains a proline-rich region, clusters of basic residues, po-
tential phosphorylation sites for casein kinase II and protein
kinase C, and a potential glycosylation site (58). Recently,
NRSs have been mapped in two non-shuttling SR proteins,
SC35 and SRp40 (33). The only apparent similarity in the
primary sequence between the NRS regions of SC35 and
human RNP C1 is within the proline-rich region. It remains
to be established whether CF Im68 contains an NRS and if it
is a shuttling protein.
Immunofluorescence localization studies showed that SR
proteins are organized in the interphase nucleus in a charac-
teristic speckled pattern and that their RS domains are re-
quired for targeting proteins to these structures (22, 59, 60).
The presence of an RS-like domain in CF Im68 prompted us to
test whether this factor localizes to splicing speckles. Localiza-
tion of CF Im subunits, both with specific antibodies and as
GFP fusions, showed that CF Im is distributed throughout the
nucleoplasm excluding the nucleoli and, in addition, concen-
trates in a few discrete foci. Double-labeling experiments with
specific antibodies directed against marker proteins of known
subnuclear compartments revealed that CF Im foci are often
located in close proximity to both Cajal bodies and splicing
speckles that do not correspond to cleavage bodies. This distri-
bution is very similar to the behavior of the PSP1, a recently
described protein of unknown function (17). This protein was
first identified by mass spectrometry as a nucleolar component.
However, localization studies detected it in a novel type of
subnuclear bodies termed paraspeckles because they are often
found close to splicing speckles (17).
Only three other proteins have been reported to localize in
paraspeckles in addition to PSP1. They are PSP2, p54nrb, and
the polypyrimidine tract-binding protein-associated splicing
factor (PSF). PSF was first identified as a factor that associates
with polypyrimidine tract-binding protein and was shown to be
required at an early step in spliceosome assembly (61). PSF
was also identified as a component of a small nuclear RNP-free
complex (SF-A) that contains U1 small nuclear RNP-specific
protein A and is implicated in 3-end processing (27). PSF and
p54nrb share considerable sequence homology and have been
shown to bind the C-terminal domain of the largest subunit of
RNA polymerase II (32). Therefore, PSF and p54nrb might
participate in coupling transcription to pre-mRNA splicing.
The identification of CF Im68 as an additional component of
2 S. Dettwiler, C. Aringhieri, S. Cardinale, W. Keller, and S. M. L.
Barabino, unpublished observations.
FIG. 8. Role of CF Im68 domains in cellular localization and
subnuclear distribution. The CF Im68 RS domain is required for
nuclear localization. HeLa cells were transfected with plasmids encod-
ing GFP-fusion proteins and fixed 24 h after transfection. The localiza-
tion of the expressed proteins was determined by indirect immunoflu-
orescence. a and a, GFP; b and b, CF Im68N; c and c, CF Im68RS46;
d and d, CF Im68RRM/RS; e and e, CF Im68RS. Bar, 5 m. DAPI,
4,6-diamidino-2-phenylindole.
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paraspeckles suggests a possible function for these structures
in the transcription and processing of pre-mRNAs.
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